Porcine neural progenitors require commitment to the oligodendrocyte lineage prior to transplantation in order to achieve significant remyelination of demyelinated lesions in the adult CNS

被引:52
作者
Smith, PM [1 ]
Blakemore, WF [1 ]
机构
[1] Univ Cambridge, Dept Clin Vet Med, Cambridge CB3 0ES, England
关键词
B104-conditioned medium; ethidium bromide; oligodendrocyte; subventricular zone;
D O I
10.1046/j.1460-9568.2000.00137.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glial cell transplantation is a potential therapy for human demyelinating disease, though obtaining large numbers of oligodendrocyte precursors from nonrodent species is currently problematic. Culturing of multipotent neural progenitors may provide a solution to this problem, because these cells can be expanded in vitro whilst retaining the ability to differentiate into both neurons and glial cells. In order to investigate the myelinating capability of multipotent neural progenitors, we isolated cells from the porcine subventricular zone, a region rich in neural progenitors, and transplanted them into areas of persistent demyelination in the spinal cord of immunosuppressed rats, created by the injection of ethidium bromide and subsequent exposure to 40 Gy X-irradiation. Porcine SVZ cells were transplanted either within 12 h of isolation or after 7 days in B104-conditioned medium. Freshly isolated cells did not mature into myelinating oligodendrocytes following transplantation and instead remained as clusters of undifferentiated progenitors. However, cells exposed to B104-conditioned medium prior to transplantation were able to effect complete remyelination of the demyelinated axons. This suggests that neural progenitors must be manipulated in vitro for commitment to the oligodendrocyte lineage prior to transplantation if significant remyelination is to be achieved.
引用
收藏
页码:2414 / 2424
页数:11
相关论文
共 60 条
[1]  
Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO
[2]  
2-5
[3]   Myelination of the canine central nervous system by glial cell transplantation: A model for repair of human myelin disease [J].
Archer, DR ;
Cuddon, PA ;
Lipsitz, D ;
Duncan, ID .
NATURE MEDICINE, 1997, 3 (01) :54-59
[4]  
Asakura K, 1997, J NEUROCHEM, V68, P2281
[5]  
AvellanaAdalid V, 1996, J NEUROSCI RES, V45, P558, DOI 10.1002/(SICI)1097-4547(19960901)45:5<558::AID-JNR6>3.0.CO
[6]  
2-B
[7]   EXTENSIVE OLIGODENDROCYTE REMYELINATION FOLLOWING INJECTION OF CULTURED CENTRAL NERVOUS-SYSTEM CELLS INTO DEMYELINATING LESIONS IN ADULT CENTRAL NERVOUS-SYSTEM [J].
BLAKEMORE, WF ;
CRANG, AJ .
DEVELOPMENTAL NEUROSCIENCE, 1988, 10 (01) :1-11
[8]   COOPERATION BETWEEN 2 GROWTH-FACTORS PROMOTES EXTENDED SELF-RENEWAL AND INHIBITS DIFFERENTIATION OF OLIGODENDROCYTE TYPE-2 ASTROCYTE (O-2A) PROGENITOR CELLS [J].
BOGLER, O ;
WREN, D ;
BARNETT, SC ;
LAND, H ;
NOBLE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6368-6372
[9]   OPTIMIZED SURVIVAL OF HIPPOCAMPAL-NEURONS IN B27-SUPPLEMENTED NEUROBASAL(TM), A NEW SERUM-FREE MEDIUM COMBINATION [J].
BREWER, GJ ;
TORRICELLI, JR ;
EVEGE, EK ;
PRICE, PJ .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 35 (05) :567-576
[10]   Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats [J].
Brüstle, O ;
Choudhary, K ;
Karram, K ;
Hüttner, A ;
Murray, K ;
Dubois-Dalcq, M ;
McKay, RDG .
NATURE BIOTECHNOLOGY, 1998, 16 (11) :1040-1044